TEL1.F SIHUAN PHARMACE

Healthcare Pharmaceuticals Frankfurt Exchange
0.0885 EUR
Close of Nov 13, 2026
0.0770 0.1788
Market cap
EUR 807M
P/E
-
P/B
1.01x
ROE
3.1%
Dividend yield
2.66%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is TEL1.F undervalued?

Graham number

The Graham number of SIHUAN PHARMACE cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SIHUAN PHARMACE fundamental analysis

No fundamental analysis for SIHUAN PHARMACE yet.

SIHUAN PHARMACE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SIHUAN PHARMACE

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculptu…

Full company profile